Skip to main content

Advertisement

SpringerLink
Log in

Surgical Oncology Forum: Tamoxifen for the Prevention of Breast Cancer in the High-Risk Woman

  • Surgical Oncology Forum
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371–1388.

    Article  CAS  PubMed  Google Scholar 

  2. Powles TJ, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998;352:98–101.

    PubMed  CAS  Google Scholar 

  3. Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women: Italian Tamoxifen Prevention Study. Lancet 1998;352:93–97.

    PubMed  CAS  Google Scholar 

  4. Lacassagne A. Hormonal pathogenesis of adenocarcinoma of the breast. Am J Cancer 1936;14:217–225.

    Google Scholar 

  5. Jensen EV, Jacobson HI. Basic guides to the mechanism of estrogen action. Recent Prog Horm Res 1962;18:387–414.

    CAS  Google Scholar 

  6. Jensen EV, Block GE, Smith S, Kyser K, DeSombre ER. Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monogr 1971;34:55–70.

    PubMed  CAS  Google Scholar 

  7. Skidmore J, Walpole AL, Woodburn J. Effect of some triphenylethylenes on oestradiol binding in vitro to macromolecules from uterus and anterior pituitary. J Endocrinol 1972;52:289–298.

    Article  PubMed  CAS  Google Scholar 

  8. Jordan VC, Koerner S. Tamoxifen (ICI 46474), and the human carcinoma 8S oestrogen receptor. Eur J Cancer 1975;11:205–206.

    PubMed  CAS  Google Scholar 

  9. Jordan VC. Effect of tamoxifen (ICI 46474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur J Cancer 1976;12:419–424.

    PubMed  CAS  Google Scholar 

  10. Gottardis MM, Jordan VC. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 1987;47:4020–4024.

    PubMed  CAS  Google Scholar 

  11. Jordan VC, Lababidi MK, Langan-Fahey S. Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy. J Natl Cancer Inst 1991;83:492–496.

    PubMed  CAS  Google Scholar 

  12. Cuzick J, Baum M. Tamoxifen and contralateral breast cancer. Lancet 1985;ii:282.

    Google Scholar 

  13. Early Breast Cancer Trialists Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998;351:1451–1467.

    Google Scholar 

  14. Terenius L. Structure-activity relationships of anti-oestrogens with regard to interaction with 17-beta-oestradiol in the mouse uterus and vagina. Acta Endocrinol (Copenh) 1971;66:431–437.

    CAS  Google Scholar 

  15. Jordan VC, Robinson SP. Species specific pharmacology of antiestrogens: role of metabolism. Fed Proc 1987;46:1870–1874.

    PubMed  CAS  Google Scholar 

  16. Jordan VC, Phelps E, Lindgren JU. Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res Treat 1987;10:31–35.

    PubMed  CAS  Google Scholar 

  17. Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC. Contrasting Contrasting trasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 1988;48:812–815.

    PubMed  CAS  Google Scholar 

  18. Love RR, Mazess RB, Barden HS, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992;326:852–856.

    Article  CAS  PubMed  Google Scholar 

  19. Love RR, Wiebe DA, Newcomb PA, et al. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med 1991;115:860–864.

    PubMed  CAS  Google Scholar 

  20. Killackey MA, Hakes TB, Pierce VK. Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treat Rep 1985;69:237–238.

    PubMed  CAS  Google Scholar 

  21. Assikis VJ, Jordan VC. Gynecologic effects of tamoxifen and the association with endometrial carcinoma. Int J Gynaecol Obstet 1995;49:241–257.

    PubMed  CAS  Google Scholar 

  22. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879–1886.

    PubMed  CAS  Google Scholar 

  23. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al model for predicting individual breast cancer risk. J Natl Cancer Inst 1994;86:600–607.

    PubMed  CAS  Google Scholar 

  24. Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994;86:620–625.

    PubMed  CAS  Google Scholar 

  25. Wickerham DL, Costantino J, Fisher B, Kavanah M, Wolmark N. Average annual rates of invasive and noninvasive breast cancer by history of LCIS and atypical hyperplasia for participants in the BCPN. Proc Am Soc Clin Oncol 99;18:87a.

  26. Powles TJ, Hardy JR, Ashley SE, et al. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 1989;60:126–131.

    PubMed  CAS  Google Scholar 

  27. Lerner LJ, Jordan VC. Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Award Lecture. Cancer Res 1990;50:4177–4189.

    PubMed  CAS  Google Scholar 

  28. Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641–1647.

    Article  CAS  PubMed  Google Scholar 

  29. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial: Multiple Outcomes of Raloxifene Evaluation. JAMA 1999;281:2189–2197.

    Article  CAS  PubMed  Google Scholar 

  30. Jordan VC, Morrow M. Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev 1999;20:253–278.

    PubMed  CAS  Google Scholar 

  31. Jordan VC. Estrogen receptor as a target for the prevention of breast cancer. J Lab Clin Med 1999;133:408–414.

    PubMed  CAS  Google Scholar 

  32. MacGregor JI, Jordan VC. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 1998;50:151–196.

    CAS  PubMed  Google Scholar 

  33. Jordan VC. Designer estrogens. Sci Am 1998;274:60–67.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lynn Sage Breast Program, Department of Surgery, Northwestern University Medical School, 676 N. St. Clair Street, 13th Floor, Room 13–104, Chicago, Illinois, 60611

    Monica Morrow MD

  2. Lynn Sage Breast Program, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, Illinois

    V. Craig Jordan PhD, DSc

Authors
  1. Monica Morrow MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Craig Jordan PhD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morrow, M., Jordan, V.C. Surgical Oncology Forum: Tamoxifen for the Prevention of Breast Cancer in the High-Risk Woman. Ann Surg Oncol 7, 67–71 (2000). https://doi.org/10.1007/s10434-000-0067-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-000-0067-0

Keywords

Search

Navigation